Summary
Hyper-IgD and periodic fever syndrome (HIDS) is a hereditary autoinflammatory syndrome, characterized by recurrent inflammatory attacks. Treatment of HIDS is difficult. Recently, the IL-1ra analogue anakinra was reported to be successful in aborting the IgD inflammatory attacks in a vaccination model. We report a clinical case of spectacular reduction of febrile attacks in a severe HIDS patient.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Georg Hoffmann
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Cailliez, M., Garaix, F., Rousset-Rouvière, C. et al. Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. J Inherit Metab Dis 29, 763 (2006). https://doi.org/10.1007/s10545-006-0408-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-006-0408-7